Skip to main content
David Harnick, MD, Cardiology, New York, NY, The Mount Sinai Hospital

DavidJHarnickMD

Cardiology New York, NY

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Assistant professor, Medicine - Cardiology, Icahn School of Medicine at Mount Sinai

Dr. Harnick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Harnick's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Clinical Cardiac Electrophysiology, 2002 - 2003
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1999 - 2002
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1996 - 1999
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1996

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1997 - 2024
  • NJ State Medical License
    NJ State Medical License 2003 - 2005
  • MD State Medical License
    MD State Medical License 1975 - 1995
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013

Publications & Presentations

PubMed

Press Mentions

  • Companies Partner with Researchers to Identify New Uses of Hemp Products
    Companies Partner with Researchers to Identify New Uses of Hemp ProductsMarch 25th, 2021
  • Cannabidiol Market Anticipated to Grow at A Lucrative Rate Through 2027 as Consumer Demand Rapidly Increases
    Cannabidiol Market Anticipated to Grow at A Lucrative Rate Through 2027 as Consumer Demand Rapidly IncreasesMarch 2nd, 2021
  • HempFusion’s Products Selected for Ground Breaking Mount Sinai CBD Cardiology Study
    HempFusion’s Products Selected for Ground Breaking Mount Sinai CBD Cardiology StudyFebruary 18th, 2021
  • Join now to see all

Hospital Affiliations